{
    "Trade/Device Name(s)": [
        "IMMULITE 2000 Vancomycin",
        "IMMULITE 2500 Vancomycin"
    ],
    "Submitter Information": "Diagnostic Products Corporation",
    "510(k) Number": "K063045",
    "Predicate Device Reference 510(k) Number(s)": [
        "K955851"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LEH"
    ],
    "Summary Letter Date": "December 5, 2006",
    "Summary Letter Received Date": "October 4, 2006",
    "Submission Date": "October 2, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.3950"
    ],
    "Regulation Name(s)": [
        "Vancomycin test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Vancomycin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (EDTA)",
        "Plasma (heparinized)",
        "SST Serum Separator Tube"
    ],
    "Specimen Container(s)": [
        "SST Serum Separator Tube",
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IMMULITE 2000 Analyzer",
        "IMMULITE 2500 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Solid phase competitive chemiluminescent enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay",
        "Chemiluminescent immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Adjustor",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE 2000/2500 Vancomycin chemiluminescent immunoassay for quantitative vancomycin monitoring in serum and plasma",
    "Indications for Use Summary": "For in vitro diagnostic use with the IMMULITE 2000 or IMMULITE 2500 Analyzer for quantitative measurement of vancomycin in serum and plasma (EDTA or heparinized), as an aid in monitoring therapeutic administration of vancomycin",
    "fda_folder": "Toxicology"
}